Search filters

List of works by Emiliano Fabiani

A case of SRSF2 mutation in chronic lymphocytic leukemia

scientific article published on 23 June 2016

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

scientific article published on 3 March 2015

Correction to Barbetti V, et al. Epigenetics Volume 8, Issue 2; pp. 210–9.

scientific article published on 28 October 2013

Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? - Response to Lucijanic and Kusec

scientific article published on 01 May 2019

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes

scientific article published on 16 September 2019

Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes

scientific article published on 24 October 2014

Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia.

scientific article published on May 2015

Epigenetic changes in therapy-related MDS/AML.

scientific article published on 27 October 2009

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

scientific article published on 3 July 2015

Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

article

Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations

scientific article published on 23 April 2019

In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome

scientific article published on 08 April 2020

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes

scientific article published on 01 September 2007

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms

scientific article published on 22 April 2014

Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies

scientific article published on 04 May 2014

Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS)

scientific article published on 08 November 2018

Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia

scientific article published on 27 May 2021

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

scientific article

Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy

scientific article

Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes

scientific article published on 22 November 2008

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

scientific article published on October 2006

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine

scientific article published on 15 July 2011

SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

scientific article published on 6 June 2014

Similarities and differences between therapy-related and elderly acute myeloid leukemia.

scientific article published on 28 November 2011

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes

scientific article published on 01 November 2013

The Role of Forkhead Box Proteins in Acute Myeloid Leukemia

scientific article published on 21 June 2019

Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells

scientific article published on January 15, 2013

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

scientific article published on 28 July 2009

Why methylation is not a marker predictive of response to hypomethylating agents.

scientific article published on April 2014